New Value Creation (Late 2000s ~)
|2008||April||Long-term goals for environmental preservation was enacted, and Teijin Group Environment-Friendly Design Guidelines were formulated.|
Innovation Research Institute (currently Iwakuni R&D Center) was established.
|June||Acquired majority stake in GH Craft Ltd., a manufacturer with an outstanding record in the design and development of advanced composite materials.|
|2009||February||Teijin Pharma Limited established Esteve Teijin Healthcare S.L.-a joint venture with leading Spanish pharmaceuticals manufacturer Laboratorios del Dr. Esteve S.A.-to oversee HOT business in Europe.|
|2010||April||Transferred stake in P.T. Teijin Indonesia Fiber Tbk to a third party.|
Developed world's first mass production technology for carbon fiber-reinforced thermoplastics (CFRTP)
|May||Teijin Pharma Limited commenced sales of hyperuricemia and gout treatment FEBURIC® (TMX-67) in Japan.|
Commenced commercial production of high-performance polyethylene products.
Lib separator production joint venture (currently Teijin Lielsort Korea Co., Ltd.) in South Korea was established.
|December||Teijin Advanced Composites America Inc. was established in the United States.|
|2012||March||Signed an agreement with the China Chemical Fibers Association to enter into a comprehensive alliance.|
Teijin Techno Products Limited and industrial fibers business of Teijin Fibers Limited were realigned and integrated into Teijin Limited.
N.I. Teijin Shoji Co., Ltd. and apparel business of Teijin Fibers Limited have been integrated and launched Teijin Frontier Co., Ltd.
Teijin Chemicals Ltd was integrated into Teijin Limited.
|May||Teijin Composites Innovation Center was moved to the Matsuyama Factory.|
|September||Joint venture Initz Co., Ltd. was established with SK Chemicals Ltd. to start polyphenylene sulfide (PPS) resins business.|
|2014||April||Teijin Product Development China Co., Ltd. was established.|
|June||Joint venture Teijin FRA Tire Cord (Thailand) Co., Ltd. was established to produce tire cords.|
Joint venture Teijin Nakashima Medical Co., Ltd., was established to facilitate entry into the market for joint prostheses.
|August||Technology Development Center was opened in Matsuyama as a development hub for high-performance material solutions.|
Started Operation of New R&D Center to accelerate material and pharmaceutical integrated development.
|2016||September||Teijin Film Solutions Limited was established as a wholly owned subsidiary as a resulf of dissolving of the joint venture arrangement with DuPont Kabushiki Kaisha for Teijin DuPont Films Japan Limited.|
Acquired Continental Structural Plastics Holdings Corporation, one of the global leaders in automotive lightweight composite technologies.
|May||Entered into an exclusive worldwide license agreement with Merck & Co., Inc., U.S.A., for the development, manufacture and commercialization of an investigational antibody candidate targeting tau, for a possible new treatment of Alzheimer's disease.|
|July||Teijin Medical Technologies Co., Ltd., was established to expand the bone-connecting material business.|
|2018||March||New carbon-fiber business subsidiary Teijin Carbon Fibers, Inc. was established in the U.S. city of Greenwood, South Carolina, the Unaited States.|
|Resin compound plant and R&D Facility was established in Teijin Corporation (Thailand) Limited.|
|April||Toho Tenax Co., Ltd. was integrated into Teijin Limited.|
|August||Acquired J.H. Ziegler GmbH, a leading supplier of automotive interior materials in Germany.|
|Acquired Inapal Plasticos SA, a leading automotive composite supplier in Portugal.|
|2019||August||Acquired Renegade Materials Corporation (Renegade), a leading North American supplier of highly heat-resistant thermoset prepreg for the aerospace industry.|
|Acquired Benet Automotive s.r.o., a leading automotive composite and component supplier in the Czech Republic.|
|October||Sold entire stake of polyester film businesses in Japan and Indonesia, Teijin Film Solutions Limited and P.T. Indonesia Teijin Film Solutions, to Toyobo Co., Ltd..|
|2020||February||Established Teijin Automotive Center Europe GmbH in Germany as a new base for technical functions in automotive composite business.|
|April||Teijin Home Healthcare Limited changed company name to Teijin Healthcare Limited.|
|August||Agreed alliance to mass produce artificial ligament with Core Tissue BioEngineering.||October||Established Teijin Visiting Nurse Station Limited for full-scale development of home-visit nursing care business.|
|Signed United Nations Global Compact's statement from Business Leaders for Renewed Global Cooperation.|
|Signed Master Contract with Safran for the purchasing of high performance composite materials.|
|December||Teijin Pharma Limited started exclusive sales of Merz's Xeomin® botulinum toxin type A in Japan.|
Continental Structural Plastics Holdings Corporation Established Advanced Technologies Center.
|Teijin Pharma Limited and TransThera Biosciences formed strategic R&D collaboration.|
|Signed comprehensive license agreement with SEMCORP to develop solvent-based coating separator s for LiBs.||2021||January||Introduced an internal carbon pricing system for capital investment plans.|
|February||Committed to Science Based Targets within two years to reduce greenhouse gas emissions.|